Skip to content

Drug interactions

Nilotinib + Trastuzumab

Severity: Moderate

Nilotinib and Trastuzumab: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs can contribute to myelosuppression and infection risk, and trastuzumab can cause cardiomyopathy while nilotinib prolongs QT. The combination is uncommon and the interaction is largely additive toxicity.

What this interaction means in plain words

Nilotinib and Trastuzumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Nilotinib belongs to Oncology; Trastuzumab belongs to Oncology.

Evidence level: Low

Why it happens

Additive pharmacodynamic toxicity, including hematologic and cardiac effects; no pharmacokinetic interaction is established.

What to do

Monitor complete blood counts and signs of infection, and assess cardiac function and ECG regularly.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Nilotinib and Trastuzumab, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Nilotinib with Trastuzumab?

MediHelp rates the interaction as moderate. Nilotinib and Trastuzumab can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs can contribute to myelosuppression and infection risk, and trastuzumab can cause cardiomyopathy while nilotinib prolongs QT. The combination is uncommon and the interaction is largely additive toxicity.

How serious is the interaction between Nilotinib and Trastuzumab?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor complete blood counts and signs of infection, and assess cardiac function and ECG regularly.

What other medicines interact with Nilotinib?

MediHelp also lists interactions of Nilotinib with, for example, Amiodarone, Arsenic trioxide, Disopyramide. The full list is on the Nilotinib page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in